Targeted therapeutic options in the treatment of Breast Cancer

Targeted therapeutic options in the treatment of Breast Cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Bibliografische gegevens
Hoofdauteur:	Alam, Kazi Tasnuva
Andere auteurs:	Kabir, Dr. Eva Rahman
Formaat:	Thesis
Taal:	en_US
Gepubliceerd in:	Brac University 2022
Onderwerpen:	Breast cancer Targeted therapy Biologics Biosimilars HER2 Trastuzumab Breast > Cancer > Patients Breast > Cancer > Treatment
Online toegang:	http://hdl.handle.net/10361/17562

Gelijkaardige items

A review on triple-negative breast cancer and its potential treatment
door: Niasa, Jannatul Ferdous
Gepubliceerd in: (2023)

Recent advancement on breast cancer detection and treatment
door: Rahman, Sanjida
Gepubliceerd in: (2023)

Natural products and their combinatory effects in breast cancer treatment
door: Siddique, Md. Ayman
Gepubliceerd in: (2021)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
door: Chakraborty, Anuradha
Gepubliceerd in: (2024)

Breast cancer awareness seminars
door: Anwer Khan Modern Medical College
Gepubliceerd in: (2016)

The impact of breast cancer on women’s lives in Bangladesh
door: Mobashera, Tayeeba Tum
Gepubliceerd in: (2024)

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
door: Akter, Honufa
Gepubliceerd in: (2024)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
door: Raihan, Dilraj
Gepubliceerd in: (2024)

Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population
door: Parvin, Salma, et al.
Gepubliceerd in: (2016)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
door: Shobnam, Sohana
Gepubliceerd in: (2024)

Breast cancer therapy through Liposomal drug delivery system
door: Ome, Nusrat Jahan
Gepubliceerd in: (2024)

Breast cancer in low-resource settings: Prioritizing the awareness and access programmes to overcome sociocultural and economic barriers for early detection and improved outcomes
door: Iqbal, Mohammad Shamim, et al.
Gepubliceerd in: (2017)

Machine learning as an indicator for breast cancer prediction
door: Shadman, Tahsin Mohammed, et al.
Gepubliceerd in: (2019)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
door: Araf, Faiaz Fahim
Gepubliceerd in: (2024)

Pathway analysis of Disease-Gene associated network in the human breast cancer
door: Lamia
Gepubliceerd in: (2020)

Early detection of breast cancer using machine learning
door: Fuad, Wasi Mohammad
Gepubliceerd in: (2019)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
door: Nuha, Nabiha Tahsin
Gepubliceerd in: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
door: Mirza, Maisa Tasnim
Gepubliceerd in: (2023)

Breast cancer in South Asia: a Bangladeshi perspective
door: Hossain, Mohammad Sorowar, et al.
Gepubliceerd in: (2017)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
door: Hasan, Sakib
Gepubliceerd in: (2024)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
door: Oishy, Jannatun Noor
Gepubliceerd in: (2024)

Biosimilar in lymphoma treatment
door: Tanisha, Mehrin Haque
Gepubliceerd in: (2021)

A review on targeted therapies for lung cancer
door: Ashraf, Anushey
Gepubliceerd in: (2023)

Breast cancer prediction using different machine learning models
door: Khandker Al- Muhaimin, et al.
Gepubliceerd in: (2020)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
door: Tania, Umme
Gepubliceerd in: (2023)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
door: Kamal, Tasnova
Gepubliceerd in: (2019)

RIPK pathway, as a potential target, for cancer treatment - a review
door: Jahan, Nusrat
Gepubliceerd in: (2024)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
door: Rahman, Qazi Ashrafur
Gepubliceerd in: (2018)

Machine learning In breast cancer prognosis and prediction
door: Chowdhury, Shah Abul Hasnat, et al.
Gepubliceerd in: (2023)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
door: Nahar, Kamrun
Gepubliceerd in: (2023)

Current practice and approaches of immunotherapy in Cancer treatment
door: Khondokar, Faiza
Gepubliceerd in: (2022)

A comprehensive review on drug repurposing in cancer treatment
door: Sarkar, Onusree
Gepubliceerd in: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
door: Meem, Manila
Gepubliceerd in: (2023)

Stem cells as therapeutic carrier in cancer treatment
door: Anika, Mysha Yeasmin
Gepubliceerd in: (2022)

Targeting BRAFV600E in the treatment of CRC
door: Roja, Mashwiyat Samrin
Gepubliceerd in: (2024)

Drug repurposing: search for targeted drug candidates in the treatment of HER2 positive breast cancer
door: Yeasmin, Jahida
Gepubliceerd in: (2024)

Microneedles in pain management of Cancer
door: Islam, Shafiqul
Gepubliceerd in: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
door: Hasan, Amit
Gepubliceerd in: (2024)

Immunotherapy in the Management of Lung Cancer
door: Tasnim, Humayra
Gepubliceerd in: (2022)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
door: Alam, Tahera
Gepubliceerd in: (2024)